Literature DB >> 19593482

[Intragastric balloon in obesity treatment].

R-A Mazure1, I Breton, E Cancer, C Mellado, V Abilés, J Avilés, M A Escarti, R Ginés, V Alvarez, N Paez, C Velasco, L Pavón, M Miras, M Martínez Olmo, J M Culebras.   

Abstract

Obesity is considered a chronic and epidemic illness, hece difficult to treat. As conservative treatment has a high rate of failure, and considering morbimortality and sequels of surgery, less invasive techniques appeared to contribute to the treatment of this illness. The most implanted technique nowadays is the Intragastric Balloon, considered more efficient as conservative treatments and with less risks tan surgery, but having today a lack of consensus on indications and few information on his limitations, while its apparition in medias promote an important expansion in the 4 last years. In this publication, we do a critical revision, and describe limitations of this treatment, based on the evidences given by literature. We conclude this revision with some recommendations concerning the technique and indications, material and human requiring, need of a Multidisciplinary Team, as well as an adequate control and following.

Entities:  

Mesh:

Year:  2009        PMID: 19593482

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  2 in total

1.  Effectiveness and safety of air-filled balloon Heliosphere BAG® in 82 consecutive obese patients.

Authors:  Edurne Lecumberri; Waeel Krekshi; Pilar Matía; Carlos Hermida; Nuria García de la Torre; Lucio Cabrerizo; Miguel Ángel Rubio
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129

2.  Preoperative intragastric balloon in morbid obesity is unable to decrease early postoperative morbidity of bariatric surgery (sleeve gastrectomy and gastric bypass): a clinical assay.

Authors:  Cristina Vicente Martin; Luis R Rabago Torre; Luis A Castillo Herrera; Marisa Arias Rivero; Miguel Perez Ferrer; David Collado Pacheco; Maria Dolores Martin Rios; Raquel Barba Martin; Javier Ramiro Martin; Jaime Vazquez-Echarri; Norberto Herrera Merino
Journal:  Surg Endosc       Date:  2019-08-09       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.